Back
NLS Pharmaceutics 10K Form
Sell
31
NLSP
NLS Pharmaceutics
Last Price:
3.46
Seasonality Move:
22.75%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NLSP News And Ratings
See the #1 stock for the next 7 days that we like better than NLSP
NLSP Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-9.40 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -6.74000 |
|---|---|
| Net Income (TTM): | $-6.6M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
NLS Pharmaceutics Earnings Forecast
Key NLS Pharmaceutics Financial Ratios
- The Interest Expense is -1.19% of Operating Income.
- Per Share Earnings over the last 7 years have been positive in 3 years.
NLS Pharmaceutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NLSP |
| Website: | nlspharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NLSP Technical Analysis vs Fundamental Analysis
Sell
31
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy or a Sell?
-
NLS Pharmaceutics stock is rated a Sell
The current NLS Pharmaceutics [NLSP] share price is $3.90. The Score for NLSP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.